Google Ads for Fertility Centers

Fertility paid search sits under two sets of rules at once, and most accounts we audit are built as though neither exists. The platform rules classify reproductive health as a sensitive category, which means remarketing on that interest is prohibited and personalized advertising for health services is unavailable. So the standard answer to a decision cycle that published sources describe as running anywhere from several weeks to twelve months is simply not available to you. The second set is stricter and less well known outside the field. The Society for Assisted Reproductive Technology maintains advertising guidelines, an Advertising Committee that reviews member clinics' websites and advertising materials, and the ability to revoke membership for non-compliance. Since SART membership status appears in the CDC's federally mandated annual report, that is a publicly visible consequence. An agency that has not read those guidelines is a liability in this vertical regardless of how good its account structure is.

1The Two Rulebooks Governing Your Ads

Take them in order of consequence, because the second one bites harder than the first.

Platform rules treat reproductive health as sensitive. Remarketing on that interest is prohibited, personalized advertising for health services is excluded, and ads cannot imply knowledge of a user's personal characteristics. Breaching these produces disapprovals and, if pursued, account suspension.

Professional rules are the more serious constraint. Reporting on the field describes SART membership as requiring clinics to report outcomes under the Fertility Clinic Success Rate and Certification Act, submit to on-site validation, maintain accredited laboratories, and adhere to ASRM and SART advertising guidelines. SART operates an Advertising Committee that reviews member websites and advertising materials, and published accounts note that programmes have been instructed to modify their advertising practices and that membership can be revoked.

The reason this matters commercially rather than just procedurally is that SART membership status is included in the CDC's federally mandated annual report on ART success rates. A membership problem is therefore visible to any patient or referring physician who looks.

2Success Rates in Advertising

This is the single highest-risk area in fertility marketing and the one clinics most want to lead with, which is a difficult combination.

The guidelines as described in published research are specific. Clinics reporting success rates are directed to provide a direct link to their Clinic Summary Report on the SART site as the primary display. Supplemental success rates are permitted where additional variables accompany them, described as live birth rate per cycle, per egg retrieval, and per embryo transfer, within each recognised SART age category. A disclaimer is expected noting that comparison of success rates may not be meaningful because patient characteristics and treatment approaches vary between clinics. Comparison marketing, meaning unsubstantiated claims of superiority over competing centres, falls outside the guidelines.

Compliance in practice has been measurably poor. One analysis of 361 SART member clinic websites found that of the 114 publishing supplemental success rates, roughly two thirds linked to their Clinic Summary Report, around half presented current data, and roughly two thirds carried the required disclaimer. A follow-up study found that most clinics cited for violations did correct them, with the most common citation concerning consistent and transparent supplemental data.

The practical consequence for a paid search account is that a headline success figure in ad copy is difficult to support, because the surrounding qualifications the guidelines contemplate do not fit in an ad. Our working position is that success rates belong on a properly constructed page that the ad points to, not in the ad itself, and that the page is built to the guidelines with your medical director's sign-off.

3Building Without Remarketing

Fertility has one of the longest decision cycles in healthcare. Published estimates vary widely, from several weeks of research in one account to three to twelve months in others, with one source describing patients visiting several clinic websites before making contact. Whichever end is closer to your market, it is a long period during which you cannot follow the person with ads.

That pushes the work to channels that remain available.

1. Organic presence across the whole journey. Published analysis puts organic at around half of fertility clinic website traffic against roughly a quarter from paid, which is consistent with a research-heavy category.
2. Branded search as the recovery channel. The person who researched in February and searches your name in June is the closest permitted equivalent to a retargeted impression, and competitors will bid on your name if you do not.
3. Owned channel follow-up. Once somebody has given you their details with appropriate consent, email and phone carry the nurture that ad platforms cannot.
4. First-visit capture. A lower-commitment step than booking a consultation, because a large share of visitors are not ready to book and you have no second chance to reach them.

Any agency proposing a fertility remarketing programme has either not read the policy or intends to breach it.

4Campaign Structure by Service Line

Fertility centres sell several distinct services to several distinct patients, and blending them produces an account that optimises toward whichever converts fastest rather than whichever matters most.

Third-party reproduction warrants particular care. State law on donor arrangements and surrogacy differs substantially and changes, so what may be advertised and to whom is a question for your counsel before campaigns are built rather than after a complaint.

5Keyword Strategy and Intent Stages

Reported click costs in this vertical are high and the published figures disagree, which is itself informative. One source puts the fertility average near $9.84 against a general healthcare figure of $5.64, while others describe ranges of $6 to $12, $5 to $15, and $8 to $45 depending on market and match type. Treat any single figure as indicative rather than as a target.

Structure by where the person is rather than only by service.

• Symptom and diagnosis stage. Trouble conceiving, irregular cycles, diagnosis terms. Early, cheaper, and frequently ignored because it does not convert immediately.
• Orientation stage. What IVF involves, how the process works, what testing precedes it. Better served by content than by a consultation ad.
• Cost and coverage stage. High intent, high volume, and the stage where honest information wins.
• Provider selection. Clinic near me, best clinic in a city, specific clinic names. The most expensive and most valuable terms.
• Branded. Your own name and your physicians' names. Physician name searches are meaningful in this field and frequently unclaimed.

On negatives, block job seeking, academic research, donor and surrogate applicant traffic where you are not recruiting, and terms relating to unproven remedies. Also consider whether you want visibility against searches that suggest acute distress rather than treatment seeking, since those clicks rarely convert and the encounter serves nobody well.

6Cost Searches and Insurance Changes

Cost is among the most searched aspects of fertility care and among the least honestly answered, which is an opportunity.

Published estimates put a single IVF cycle in the region of $15,000 to $25,000 including medication, with all-in figures frequently reported at $20,000 to $30,000 or more once genetic testing, freezing, and transfer are included, and with wide state-level variation. Consumer-facing analysis has criticised the pattern of advertising an attractive base price while charging separately for monitoring, anaesthesia, ICSI, freezing, or transfer.

That criticism is worth taking seriously as a positioning decision. A clinic that publishes a genuinely itemised cost picture differentiates against a category with a reputation for the opposite, and it also pre-qualifies enquiries so consultations start from realistic expectations.

Insurance coverage is changing and campaigns should reflect it. California's SB 729, reported as effective from January 2026, requires many employer-sponsored plans in that state to cover IVF. Where a mandate applies in your market, coverage-related search demand rises and the messaging shifts from whether treatment is affordable to whether a patient qualifies. Check the current position in your own states rather than assuming, since this area is moving.

7Ad Copy in an Emotionally Loaded Category

The person reading your ad may have been trying to conceive for years. ASRM commentary has warned that promoting treatments with promises of high success rates, or glamorising procedures without discussing risks, can contribute to patient disillusionment and pressure. That is a professional body describing marketing practice in its own field, and it is worth treating as guidance rather than criticism of someone else.

What that rules out is most of the conventional persuasion toolkit. No urgency mechanics, since a countdown on fertility treatment is indefensible. No success rate claims in the ad itself. No imagery or language implying a guaranteed outcome. No copy built on the fear of running out of time, which is both manipulative and clinically simplistic.

What works instead is specific and calm. Physician credentials and board certification. What the first consultation involves and what it costs. How quickly a patient can be seen, which matters enormously to this audience. The services offered and the pathways available. That your clinic reports to SART and CDC, which is a meaningful signal to an informed patient.

Extensions should carry the same content. Consultation availability, physician names, location, and financial information do more here than a discount ever would.

8Landing Pages and Review Exposure

Destination pages are reviewed alongside the ads by the platform, and separately by the SART Advertising Committee, which reviews member websites. Your landing page is therefore under two forms of scrutiny.

Build it accordingly. Present success rates only in the structure the guidelines contemplate, with the Clinic Summary Report link, the denominators identified, age categories included, and the comparison disclaimer present. Avoid superiority claims relative to other clinics entirely. Present cost information completely. Name the physicians and their credentials.

Handle patient stories carefully. Birth announcements and baby imagery are the emotional centre of fertility marketing and they carry two problems. They function as implied outcome claims in a field where outcomes are uncertain, and they require documented patient authorisation rather than casual permission. They are also seen by patients whose treatment did not succeed, which is a meaningful proportion of any clinic's population.

Finally, treat tracking as a privacy question before a measurement one. Third-party tags on pages where patients book, complete intake, or access records create a data flow that needs review, and reproductive health information is among the most sensitive categories there is.

9Measuring to Booked Consultations

Cost per lead is close to meaningless in this category, because the gap between an enquiry and a booked consultation is wide and the gap between a consultation and a started cycle is wider. One published account describes two to four consultations per started cycle, with all-in acquisition costs of roughly $200 to $600 per IVF start through paid channels.

Measure the whole sequence. Enquiries, consultations booked, consultations attended, and cycles started, by source and by service line. Reported cost per lead figures in this vertical range from around $112 in one dataset to $150 to $350 for IVF campaigns in another, and the variation between them is largely definitional.

The economics support patience. Published estimates put per-patient revenue across a treatment journey at $40,000 to $80,000 when a relationship spans testing, multiple cycles, transfers, and later siblings. That justifies an acquisition cost that would be alarming in most medical specialties, and it means a slightly more expensive consultation from a high-trust channel routinely beats a cheap click that never converts.

Push conversions back into the platform only within whatever boundaries your privacy review sets. Where connecting patient data to advertising systems is not appropriate, run the analysis in your own systems and use it to inform manual decisions.

For general platform mechanics rather than this vertical's constraints, our Google Ads guide covers campaign types, bidding, and structure.